Literature DB >> 6450894

[13-cis-Retinoic acid. Pharmacologic and toxicologic findings in treatment of severe forms of acne (author's transl)].

A Wagner, G Plewig.   

Abstract

This study shows that severe acne is characterized by numerous inflammatory parameters. The group of acne tetrad patients differed from those with conglobate acne in many laboratory measurements. The treatment with 13-cis-retinoic acid was well tolerated by all patients. Sebum suppression and an exfoliative cheilitis occurred in all patients, but no headache and no loss hair. Numerous previously pathological blood chemical values were normalized during the treatment. Transaminases, alkaline phosphatase, triglycerides and total cholesterol did not rise noticeably, trichological and spermatological parameters were not affected by 13-cis-retinoic acid. In an in vivo epicutaneous potassium iodide inflammation model, it was possible to demonstrate for the first time the anti-inflammatory action of 13-cis-retinoic acid.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6450894

Source DB:  PubMed          Journal:  MMW Munch Med Wochenschr        ISSN: 0341-3098


  6 in total

Review 1.  The retinoids. A review of their clinical pharmacology and therapeutic use.

Authors:  C E Orfanos; R Ehlert; H Gollnick
Journal:  Drugs       Date:  1987-10       Impact factor: 9.546

2.  13-cis-retinoic acid in conglobate acne. A follow-up study of 14 trial centers.

Authors:  R Hennes; A Mack; H Schell; H J Vogt
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

3.  Reduction of bacterial skin flora during oral treatment of severe acne with 13-cis retinoic acid.

Authors:  A Weissmann; A Wagner; G Plewig
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

4.  Anti-inflammatory effects of 13-Cis-retinoic acid. An in vivo study.

Authors:  G Plewig; A Wagner
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

5.  Inhibitory effects of 13-cis-retinoic acid on human sebaceous glands.

Authors:  M Landthaler; J Kummermehr; A Wagner; G Plewig
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

6.  Treatment of gram-negative folliculitis with isotretinoin.

Authors:  U Neubert; G Plewig; A Ruhfus
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.